B 663 (Lampren) in mycobacterial infections.
D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D009164:Mycobacterium Infections / Q000188:drug therapy*; D010619:Phenazines / Q000009:adverse effects / Q000627:therapeutic use*; D010859:Pigmentation Disorders / Q000139:chemically induced; D012874:Skin Diseases, Infectious / Q000188:drug therapy
D010619:Phenazines